Table 1. Reported sensitivity and specificity of urine-based single protein biomarkers for the detection of bladder cancer.
Protein name | Sensitivity (%) | Specificity (%) | Cancer (n) | Control (n) | Ref. |
---|---|---|---|---|---|
Alpha-1-anti-trypsin | 74 | 80 | 54 | 46 | [32] |
Alpha-1-anti-trypsin | 71 | 72 | 102 | 206 | [40] |
Angiogenin | 66 | 75 | 50 | 40 | [41] |
Apolipoprotein A1 | 95 | 92 | 49 | 37 | [42] |
Apolipoprotein A4 | 79 | 100 | 110 | 66 | [18] |
AMFR | 84 | 75 | 45 | 62 | [43] |
BIGH3 | 93 | 80 | 30 | 15 | [44] |
Calprotectin | 80 | 93 | 46 | 40 | [45] |
Cathepsin B | 56 | 56 | 122 | 107 | [46] |
Cathepsin L | 71 | 75 | 122 | 107 | [46] |
CCL18 | 70 | 68 | 102 | 206 | [40] |
CD147 | 97 | 100 | 30 | 15 | [44] |
CEACAM1 | 74 | 95 | 95 | 82 | [47] |
Clusterin | 68 | 61 | 68 | 61 | [48] |
Clusterin | 70 | 83 | 50 | 40 | [41] |
Coronin-1A | 67 | 100 | 110 | 66 | [18] |
CXCL1 | 72 | 95 | 95 | 30 | [49] |
CXCL1 | 56 | 84 | 43 | 43 | [50] |
CYFRA21-1 | 79 | 89 | 82 | 70 | [51] |
CYFRA21-1 | 81 | 97 | 86 | 76 | [52] |
CYFRA21-1 | 70 | 43 | 125 | 321 | [53] |
CYFRA21-1 | 97 | 67 | 48 | 80 | [54] |
DJ1 | 83 | 100 | 110 | 66 | [18] |
EN2 | 82 | 75 | 466 | 55 | [55] |
FDP | 52 | 91 | 57 | 139 | [56] |
Fibronectin | 91 | 88 | 75 | 55 | [57] |
Fibronectin | 72 | 82 | 126 | 41 | [58] |
Prothrombin | 71 | 75 | 76 | 80 | [17] |
Reg-1 | 81 | 81 | 23 | 48 | [59] |
Semenogelin-2 | 67 | 80 | 110 | 66 | [18] |
Stathmin-1 | 90 | 87 | 30 | 15 | [44] |
Telomerase | 70 | 99 | 57 | 139 | [56] |
Telomerase | 83 | 89 | 73 | 37 | [60] |
g-synuclein | 88 | 90 | 110 | 66 | [18] |